Magnetic Resonance Spectroscopy in Clinical Oncology

@article{Golder2004MagneticRS,
  title={Magnetic Resonance Spectroscopy in Clinical Oncology},
  author={W. Golder},
  journal={Oncology Research and Treatment},
  year={2004},
  volume={27},
  pages={304 - 309}
}
  • W. Golder
  • Published 2004
  • Medicine
  • Oncology Research and Treatment
    • The combination of magnetic resonance spectroscopy (MRS) and imaging (MRI) has led to mapping metabolites from normal and neoplastic tissue within the time limits of a routine study. MRSI (magnetic resonance spectroscopy imaging) detects metabolites that contain protons, phosphorus, fluorine, or other nuclei. The uniqueness of the information available in vivo and in a non-invasive manner encouraged radiologists and oncologists to apply MRSI in research and clinical practice. Both 1H- and 31P… CONTINUE READING
    View on PubMed
    doi.org
    Top 3 of 27 Citations
    In vivo magnetic resonance spectroscopy in cancer.
    R. Gillies, D. MorseAnnual review of biomedical engineering2005
    235
    Feasibility of In vivo Proton Magnetic Resonance Spectroscopy for Lung Cancer
    S. H. Yoon, Chang Min Park, … J. Goo2012
    2
    Metabolic brain imaging by magnetic resonance
    E. Novotny2006
    2
    27 Citations
    Fields of Study

    Fields of Study

    Citation Type

    Citation Type

    In vivo magnetic resonance spectroscopy in cancer.
    235
    Feasibility of In vivo Proton Magnetic Resonance Spectroscopy for Lung Cancer
    2
    Metabolic brain imaging by magnetic resonance
    2
    Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T
    25
    Clinical 1h magnetic resonance spectroscopy of brain metastases at 1.5T and 3T
    15
    Imaging of brain tumors: MR spectroscopy and metabolic imaging.
    188
    In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
    33
    Evaluating pH in the Extracellular Tumor Microenvironment Using CEST MRI and Other Imaging Methods.
    46
    Investigation of compressed-sensing for acceleration of magnetic resonance spectroscopic imaging
    1
    Utilization of advanced imaging technologies for target delineation in radiation oncology.
    40

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 38 REFERENCES
    In Vivo Proton (H1) Magnetic Resonance Spectroscopy for Cervical Carcinoma
    43
    The potential of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis and management of patients with brain tumors
    52
    Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.
    346
    Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
    257
    In vivo proton magnetic resonance spectroscopy of diseased prostate: spectroscopic features of malignant versus benign pathology.
    64
    Developments in nuclear magnetic resonance imaging and spectroscopy: application to radiation oncology.
    17
    Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors.
    84
    Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.
    159
    Tumor metabolism: the lessons of magnetic resonance spectroscopy.
    50
    MR spectroscopy of musculoskeletal soft-tissue tumors.
    8